Management consideration for patient with a large solitary fibrous tumor occupying the infratemporal fossa: A case report

Adachi,Makoto; Motohashi,Masayuki; Kaku,Yasuhiko; Sugie,Shigeyuki; Muramatsu,Yasunori; Sumitomo,Shinichiro

doi:10.3892/mco.2018.1575

Management consideration for patient with a large solitary fibrous tumor occupying the infratemporal fossa: A case report

Authors:
- Makoto Adachi
- Masayuki Motohashi
- Yasuhiko Kaku
- Shigeyuki Sugie
- Yasunori Muramatsu
- Shinichiro Sumitomo
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Asahi University Murakami Memorial Hospital, Gifu 500‑8523, Japan, Department of Neurosurgery, Asahi University Murakami Memorial Hospital, Gifu 500‑8523, Japan, Department of Pathology, Asahi University Murakami Memorial Hospital, Gifu 500‑8523, Japan, Department of Oral and Maxillofacial Surgery, Division of Oral Pathogenesis and Disease Control, Asahi University, School of Dentistry, Mizuho, Gifu 501‑0296, Japan
Published online on: February 15, 2018 https://doi.org/10.3892/mco.2018.1575
Pages: 544-548
Copyright: © Adachi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The solitary fibrous tumor (SFT) was first described as a mesenchymal tumor of fibroblastic type, present in the pleura. The head and neck area is the third most common site of SFT occurrence. Numb chin syndrome (NCS) is a rare neurological symptom. The current report describes the case of a 39‑year‑old female patient referred to the present hospital with NCS, which was later observed to be due to a large SFT in the infratemporal fossa. Computed tomography and magnetic resonance images were taken and subsequent examination of these images revealed a space occupying mass (52x50x40 mm) in the infratemporal fossa. An open biopsy was performed on the lower part of the right auricula following angiography assisted vascular embolization of the maxillary artery. Pathological diagnosis was verified as SFT. Despite the tumor size and anatomical site, the SFT was successfully reduced in size by treatment with intensity modulated radiation therapy (IMRT) alone, with no recurrence. IMRT treatment of SFT may be effective as a future potential option for locally advanced head and neck SFT.

View Figures

View References

1	Klemperer P and Rabin C: Primary neoplasms of the pleura. A report of five cases. Am J Ind Med. 22:1–31. 1992. View Article : Google Scholar : PubMed/NCBI
2	Stout AP and Murray MR: Hemangiopericytoma: A vascular tumor featuring zimmermann's pericytes. Ann Surg. 116:26–33. 1942. View Article : Google Scholar : PubMed/NCBI
3	Doyle LA: Sarcoma classification: An update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone. Cancer. 120:1763–1774. 2014. View Article : Google Scholar : PubMed/NCBI
4	Koch M, Nielsen GP and Yoon SS: Malignant tumors of blood vessels: Angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol. 97:321–329. 2008. View Article : Google Scholar : PubMed/NCBI
5	Fareed MM, Al Amro AS, Akasha R, Al Assiry M, Al Asiri M, Tonio M and Bayoumi Y: Parapharyngeal space hemangiopericytoma treated with surgery and postoperative radiation-a case report. Head Neck Oncol. 4:102012. View Article : Google Scholar : PubMed/NCBI
6	Smith RM, Hassan A and Robertson CE: Numb chin syndrome. Curr Pain Headache Rep. 19:442015. View Article : Google Scholar : PubMed/NCBI
7	Buchanan G: Two rare tumours involving the infratemporal fossa: Alveolar soft part sarcoma and haemangiopericytoma. J Laryngol Otol. 89:375–389. 1975. View Article : Google Scholar : PubMed/NCBI
8	Kanazawa T, Nishino H, Miyata M, Kuriki K, Abe K and Ichimura K: Haemangiopericytoma of infratemporal fossa. J Laryngol Otol. 115:77–79. 2001. View Article : Google Scholar : PubMed/NCBI
9	Brucoli M, Giarda M, Valente G and Benech A: Hemangiopericytoma of the infratemporal fossa: Progression toward malignancy in a 30-year history. J Craniofac Surg. 16:1146–1150. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bianchi B, Poli T, Bertolini F and Sesenna E: Malignant hemangiopericytoma of the infratemporal fossa: Report of a case. J Oral Maxillofac Surg. 60:309–312. 2002. View Article : Google Scholar : PubMed/NCBI
11	Penel N, Amela EY, Decanter G, Robin YM and Marec-Berard P: Solitary fibrous tumors and so-called hemangiopericytoma. Sarcoma. 2012:6902512012. View Article : Google Scholar : PubMed/NCBI
12	Ambrosini-Spaltro A and Eusebi V: Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: A comparison. Virchows Arch. 456:343–354. 2010. View Article : Google Scholar : PubMed/NCBI
13	Fletcher CD, Bridge J and Lee J: World Health Organization Classification of Tumours of Soft Tissue and Bone. IARC Press; Lyon, France: 2013
14	Koscielny S, Bräuer B and Förster G: Hemangiopericytoma: A rare head and neck tumor. Eur Arch Otorhinolaryngol. 260:450–453. 2003. View Article : Google Scholar : PubMed/NCBI
15	Schirmer CM and Heilman CB: Hemangiopericytomas of the skull base. Neurosurg Focus. 30:E102011. View Article : Google Scholar : PubMed/NCBI
16	Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS and Araujo DM: The role of chemotherapy in advanced solitary fibrous tumors: A retrospective analysis. Clin Sarcoma Res. 3:72013. View Article : Google Scholar : PubMed/NCBI
17	Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, et al: Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 117:4939–4947. 2011. View Article : Google Scholar : PubMed/NCBI
18	Stacchiotti S, Negri T, Palassini E, Conca E, Gronchi A, Morosi C, Messina A, Pastorino U, Pierotti MA, Casali PG and Pilotti S: Sunitinib malate and figitumumab in solitary fibrous tumor: Patterns and molecular bases of tumor response. Mol Cancer Ther. 9:1286–1297. 2010. View Article : Google Scholar : PubMed/NCBI
19	Domont J, Massard C, Lassau N, Armand JP, Le Cesne A and Soria JC: Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma/solitary fibrous tumour. Invest New Drugs. 28:199–202. 2010. View Article : Google Scholar : PubMed/NCBI
20	Sleijfer S, Ray-Coquard I, Papai Z, Le Cesne A, Scurr M, Schöffski P, Collin F, Pandite L, Marreaud S, De Brauwer A, et al: Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: A phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol. 27:3126–3132. 2009. View Article : Google Scholar : PubMed/NCBI
21	Quek R, Wang Q, Morgan JA, Shapiro GI, Butrynski JE, Ramaiya N, Huftalen T, Jederlinic N, Manola J, Wagner AJ, et al: Combination mTOR and IGF-1R inhibition: Phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res. 17:871–879. 2011. View Article : Google Scholar : PubMed/NCBI